Tocilizumab treatment in severe COVID-19: a multicenter retrospective study with matched controls
Sign Up to like & getrecommendations! Published in 2021 at "Rheumatology International"
DOI: 10.1007/s00296-021-04965-6
Abstract: Coronavirus disease-2019 (COVID-19) associated pneumonia may progress into acute respiratory distress syndrome (ARDS). Some patients develop features of macrophage activation syndrome (MAS). Elevated levels of IL-6 were reported to be associated with severe disease, and… read more here.
Keywords: tocilizumab treatment; intubation; study; tocilizumab users ... See more keywords
Effect of Tocilizumab Treatment on Patients with Coronavirus Disease 2019 and Bacteremia: A Retrospective Cohort Study
Sign Up to like & getrecommendations! Published in 2022 at "Infectious Diseases and Therapy"
DOI: 10.1007/s40121-022-00592-1
Abstract: Introduction This study aimed to determine if tocilizumab treatment for coronavirus disease 2019 (COVID-19) increases bacteremia and suppresses fever and inflammatory reactants. Methods In this single-center, retrospective, observational study, all patients with COVID-19 admitted to… read more here.
Keywords: study; bacteremia; tocilizumab; tocilizumab treatment ... See more keywords
Tocilizumab for treatment patients with COVID-19: Recommended medication for novel disease
Sign Up to like & getrecommendations! Published in 2020 at "International Immunopharmacology"
DOI: 10.1016/j.intimp.2020.107018
Abstract: The coronavirus disease 2019 (COVID-19) virus has spread all over the world. Scientists are trying to discover drugs as effective treatment for patients with COVID-19. So far about 30 drugs have been introduced that one… read more here.
Keywords: tocilizumab treatment; treatment patients; disease; tocilizumab ... See more keywords
OA31 Real life experience of tocilizumab treatment for giant cell arteritis
Sign Up to like & getrecommendations! Published in 2023 at "Rheumatology"
DOI: 10.1093/rheumatology/kead104.031
Abstract: Giant cell arteritis (GCA) has been revolutionised by fast track pathways that ensure early secure diagnosis. The GiACTA study provided evidence for the beneficial role of tocilizumab in the treatment of GCA and encouraged us… read more here.
Keywords: tocilizumab treatment; rheumatology; relapsing disease; tocilizumab ... See more keywords
Effectiveness of tocilizumab in the treatment of hospitalized adults COVID-19
Sign Up to like & getrecommendations! Published in 2022 at "Medicine"
DOI: 10.1097/md.0000000000028967
Abstract: Abstract Background: Since December 2019, the coronavirus disease (COVID-19) has spread worldwide, leading to a global health threat. This study aimed to investigate the effectiveness of tocilizumab in COVID-19 patients. Methods: We systematically searched PubMed,… read more here.
Keywords: tocilizumab treatment; effectiveness tocilizumab; adults covid; care ... See more keywords
Tocilizumab Treatment Effect on Iron Homeostasis in Severe COVID-19 Patients
Sign Up to like & getrecommendations! Published in 2022 at "Acta Haematologica"
DOI: 10.1159/000522307
Abstract: Background: Tocilizumab has been proposed as an effective treatment for severe COVID-19. We aimed to investigate whether tocilizumab administration is associated with increased availability of serum iron which may possibly be associated with adverse effects… read more here.
Keywords: tocilizumab treatment; severe covid; serum; iron ... See more keywords
Tocilizumab for the Treatment of SLC29A3 Mutation Positive PHID Syndrome
Sign Up to like & getrecommendations! Published in 2017 at "Pediatrics"
DOI: 10.1542/peds.2016-3148
Abstract: Tocilizumab profoundly improved the inflammatory features of PHID and thus may be beneficial for PHID-associated autoinflammation. Pigmentary hypertrichosis and non-autoimmune insulin-dependent diabetes mellitus (PHID) is associated with recessive mutations in SLC29A3, encoding the equilibrative nucleoside… read more here.
Keywords: autoinflammation; phid syndrome; phid; tocilizumab treatment ... See more keywords
Psoas and Mediastinal Abscesses during Intravenous Tocilizumab Treatment in Multicentric Castleman Disease
Sign Up to like & getrecommendations! Published in 2022 at "Internal Medicine"
DOI: 10.2169/internalmedicine.9519-22
Abstract: Tocilizumab has been used to treat idiopathic multicentric Castleman disease (iMCD). As tocilizumab prevents interleukin-6 from exerting pro-inflammatory effects, there is some concern about a delayed diagnosis of severe infections during tocilizumab treatment. Although serious… read more here.
Keywords: tocilizumab treatment; psoas mediastinal; castleman disease; multicentric castleman ... See more keywords
Tocilizumab for treatment of SARS-CoV-2 infection at home: A case report.
Sign Up to like & getrecommendations! Published in 2022 at "Acute medicine"
DOI: 10.52964/amja.0894
Abstract: SARS-CoV-2 virtual wards have successfully developed to monitor and escalate patients to hospital throughout the pandemic. Here we describe the case of an 84 year old man who received his complete care for severe SARS-CoV-2… read more here.
Keywords: tocilizumab treatment; treatment sars; case; home ... See more keywords